PAVmed Inc. PAVM
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 33.00K | 22.00K | 52.00K | 5.00K | 6.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 33.00K | 22.00K | 52.00K | 5.00K | 6.00K |
| Cost of Revenue | 122.00K | 97.00K | 85.00K | 55.00K | 41.00K |
| Gross Profit | -89.00K | -75.00K | -33.00K | -50.00K | -35.00K |
| SG&A Expenses | 4.87M | 6.57M | 4.94M | 3.71M | 3.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.06M | 8.06M | 6.86M | 4.85M | 4.72M |
| Operating Income | -7.02M | -8.04M | -6.80M | -4.84M | -4.72M |
| Income Before Tax | -6.60M | -1.06M | -2.76M | -6.01M | -12.32M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.60M | -1.06M | -2.76M | -6.01M | -12.32M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1.21M | 1.00M | 1.49M | 628.00K | 403.00K |
| Net Income | -5.38M | -60.00K | -1.26M | -5.38M | -11.92M |
| EBIT | -7.02M | -8.04M | -6.80M | -4.84M | -4.72M |
| EBITDA | -7.00M | -8.02M | -6.79M | -4.82M | -4.69M |
| EPS Basic | -0.87 | -4.42 | 0.45 | -8.81 | -22.08 |
| Normalized Basic EPS | -0.16 | -0.50 | 0.05 | -0.46 | -0.87 |
| EPS Diluted | -0.87 | -4.42 | -4.07 | -8.81 | -22.08 |
| Normalized Diluted EPS | -0.16 | -0.50 | 0.05 | -0.46 | -0.87 |
| Average Basic Shares Outstanding | 6.27M | 1.58M | 895.20K | 718.50K | 602.80K |
| Average Diluted Shares Outstanding | 6.27M | 1.58M | 895.20K | 718.50K | 602.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |